Literature DB >> 22749961

Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life.

Andrea Siebenhofer1, Lars G Hemkens, Ivo Rakovac, Stephan Spat, Ulrike Didjurgeit.   

Abstract

UNLABELLED: BACKGROUND - RATIONALE FOR STUDY: In elderly patients, long-term self-management of oral anticoagulation has been shown to reduce the number of major thromboembolic and bleeding complications and improve the quality of oral anticoagulation (OAC) control compared to routine care for a mean follow-up period of three years. This article presents the results of the predefined secondary endpoint treatment-related quality of life (QoL). METHODS AND
RESULTS: The effect of self-management on five aspects of QoL was evaluated in comparison with routine care. A validated questionnaire specifically designed for patients receiving OAC was used. The evaluation was possible for 141 patients, comprising 90% of surviving patients on OAC. At baseline, all patients had high scores for the following QoL-aspects: general treatment satisfaction, self-efficacy, daily hassles and strained social network. A high proportion of patients in both groups explicitly reported high distress, indicating that general psychological distress seems to be of particular concern in this population. After about 3 years of follow-up, patients performing self-management showed a significantly greater improvement in general treatment satisfaction than controls (median score increase [25th percentile, 75th percentile]: 0.9 [0.0, 1.6] vs. 0.0 [-0.2, 0.6], p=0.002; scale 1-6). Changes in general psychological distress, self-efficacy, daily hassles and strained social network were not significant.
CONCLUSION: Treatment related quality of life in elderly patients performing self-management of OAC was similar as for patients in routine care setting, with a tendency of higher general treatment satisfaction, after three years of follow up.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749961     DOI: 10.1016/j.thromres.2012.06.012

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Quality of life with rivaroxaban in patients with non-valvular atrial fibrilation by therapeutic compliance.

Authors:  Emilio Márquez-Contreras; Nieves Martell-Claros; Vicente Gil-Guillén; Mariano De la Figuera-Von Wichmann; Eugenio Sánchez-López; Ines Gil-Gil; Sara Márquez-Rivero
Journal:  Qual Life Res       Date:  2017-01-06       Impact factor: 4.147

2.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

Review 3.  Self-monitoring and self-management of oral anticoagulation.

Authors:  Carl J Heneghan; Josep M Garcia-Alamino; Elizabeth A Spencer; Alison M Ward; Rafael Perera; Clare Bankhead; Pablo Alonso-Coello; David Fitzmaurice; Kamal R Mahtani; Igho J Onakpoya
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05

Review 4.  Self-management of oral anticoagulation.

Authors:  Andrea Siebenhofer; Klaus Jeitler; Karl Horvath; Wolfgang Habacher; Louise Schmidt; Thomas Semlitsch
Journal:  Dtsch Arztebl Int       Date:  2014-02-07       Impact factor: 5.594

5.  New oral anticoagulants vs vitamin K antagonists: benefits for health-related quality of life in patients with atrial fibrillation.

Authors:  Josep M Alegret; Xavier Viñolas; Miguel A Arias; Antoni Martínez-Rubio; Pablo Rebollo; Carles Ràfols; José L Martínez-Sande
Journal:  Int J Med Sci       Date:  2014-05-01       Impact factor: 3.738

Review 6.  International normalized ratio self-testing and self-management: improving patient outcomes.

Authors:  Matteo Pozzi; Julia Mitchell; Anna Maria Henaine; Najib Hanna; Ola Safi; Roland Henaine
Journal:  Vasc Health Risk Manag       Date:  2016-10-12

7.  Cost-effectiveness analysis of case management for optimized antithrombotic treatment in German general practices compared to usual care - results from the PICANT trial.

Authors:  Lisa R Ulrich; Juliana J Petersen; Karola Mergenthal; Andrea Berghold; Gudrun Pregartner; Rolf Holle; Andrea Siebenhofer
Journal:  Health Econ Rev       Date:  2019-02-07

8.  Primary care management for optimized antithrombotic treatment [PICANT]: study protocol for a cluster-randomized controlled trial.

Authors:  Andrea Siebenhofer; Lisa R Ulrich; Karola Mergenthal; Ina Roehl; Sandra Rauck; Andrea Berghold; Sebastian Harder; Ferdinand M Gerlach; Juliana J Petersen
Journal:  Implement Sci       Date:  2012-08-28       Impact factor: 7.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.